Zhong Ji LS Announces 30 June 2026 AGM; Seeks Approval for FY-2025 Results, Board Re-election and 20% Issuance Mandate

Bulletin Express
Jun 08

Zhong Ji Longevity Science Group Limited (abbreviated: Zhong Ji LS) has issued its proxy form and agenda for the Annual General Meeting (AGM) scheduled for 30 June 2026 at 10:30 a.m. at 30/F, Harbour Side HQ, 8 Lam Chak Street, Kowloon Bay, Hong Kong.

Key matters to be tabled as ordinary resolutions include:

1. Financial Statements • Shareholders will vote on receiving and considering the audited consolidated financial statements for the year ended 31 December 2025, together with the directors’ and auditor’s reports.

2. Board Composition and Remuneration • Re-election of four directors: – Mr. Yan Li (Executive Director) – Mr. Lyu Changsheng (Non-executive Director) – Ms. Wang Huijuan (Independent Non-executive Director) – Ms. Tam Mei Chu (Independent Non-executive Director) • Authorisation for the board to determine directors’ remuneration for the ensuing year.

3. Auditor Appointment • Proposal to re-appoint CCTH CPA Limited as the Company’s auditor until the next AGM and to empower the board to fix its remuneration.

4. Share Capital Mandates • General mandate permitting the board to issue and deal with additional shares representing up to 20% of the total shares in issue as at the date of the resolution. • Authority to repurchase shares on-market up to 10% of the issued share capital. • Extension of the 20% issuance mandate by adding the number of shares repurchased under the 10% buy-back authority.

Shareholders who wish to vote via proxy must submit duly completed proxy forms to the Hong Kong branch share registrar, Computershare Hong Kong Investor Services Limited, no later than 48 hours before the meeting. Attendance in person remains an option, with any lodged proxy rendered void upon personal attendance.

These resolutions collectively address corporate governance, capital management flexibility, and auditor continuity as Zhong Ji LS prepares to review its FY-2025 performance and strategic mandates for the coming year.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10